Royalty Pharma plc【RPRX】Cash flow
Market cap
$23.4B
P/E ratio
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash from operations | 2,035 | 2,018 | 2,144 | 2,988 | 2,769 |
| Cash from investing | -2,759 | -1,870 | -1,029 | -2,073 | -2,678 |
| Repurchases of common stock | - | - | - | 305 | 230 |
| Proceeds from issuance of term debt, net | 11,891 | 1,273 | - | - | - |
| Repayments of term debt | 11,116 | - | - | - | - |
| Cash from financing | 1,487 | 385 | -945 | -2,149 | 361 |